Related references
Note: Only part of the references are listed.The epidemiology of infectious mononucleosis in Northern Scotland: a decreasing incidence and winter peak
Elizabeth Visser et al.
BMC INFECTIOUS DISEASES (2014)
Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation
Michael Uhlin et al.
HAEMATOLOGICA (2014)
Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
Catherine M. Bollard et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus
Peter Hanlon et al.
ARTHRITIS RESEARCH & THERAPY (2014)
EBV-positive diffuse large B-cell lymphoma of the elderly
Chi Young Ok et al.
BLOOD (2013)
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
Ann M. Leen et al.
BLOOD (2013)
Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus-Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Jan Styczynski et al.
CLINICAL INFECTIOUS DISEASES (2013)
Post-Transplantation Lymphoproliferative Disorder After Kidney Transplantation: Report of a Nationwide French Registry and the Development of a New Prognostic Score
Sophie Caillard et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant
Ulrike Gerdemann et al.
MOLECULAR THERAPY (2013)
Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis
Yahya H. Almohmeed et al.
PLOS ONE (2013)
EBV-associated lymphomas in adults
Mark Roschewski et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2012)
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
Ekaterina Doubrovina et al.
BLOOD (2012)
Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease
Michael Uhlin et al.
CLINICAL INFECTIOUS DISEASES (2012)
Epstein-Barr Virus-associated Gastric Carcinoma A Newly Defined Entity
Jian-Ning Chen et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
T-cell therapy in the treatment of post-transplant lymphoproliferative disease
Catherine M. Bollard et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma
Stefan D. Dojcinov et al.
BLOOD (2011)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
Juliet N. Barker et al.
BLOOD (2010)
Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
Andreas Moosmann et al.
BLOOD (2010)
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience
Conrad Russell Cruz et al.
CYTOTHERAPY (2010)
Allogeneic T-Cell Therapy for Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease: Long-Term Follow-Up
Tanzina Haque et al.
TRANSPLANTATION (2010)
CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells
Heather M. Long et al.
BLOOD (2009)
Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition
Dagmar Berghuis et al.
JOURNAL OF PATHOLOGY (2009)
Lymphoproliferative Disorders and De Novo Malignancies in Intestinal and Multivisceral Recipients: Improved Outcomes With New Outlooks
Kareem M. Abu-Elmagd et al.
TRANSPLANTATION (2009)
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque et al.
BLOOD (2007)
Single agent efficacy of rituximab in childhood immunosuppression related lymphoproliferative disease: a United Kingdom Children's Cancer Study Group (UKCCSG) retrospective review
Boo Messahel et al.
LEUKEMIA & LYMPHOMA (2006)
Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of Epstein-Barr virus-associated diseases
GM Wilkie et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma
Q Sun et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells
T Haque et al.
LANCET (2002)
Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells
T Haque et al.
TRANSPLANTATION (2001)
Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity
E Derby et al.
IMMUNOLOGY LETTERS (2001)
Share Paper
